SEC Info - American Renal Associates Holdings, Inc. - ‘10-Q’ for 3/31/17

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    520K 
 2: EX-10.1     Material Contract                                   HTML     43K 
 3: EX-10.2     Material Contract                                   HTML     40K 
 4: EX-10.3     Material Contract                                   HTML     39K 
 5: EX-10.4     Material Contract                                   HTML     41K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
16: R1          Document and Entity Information                     HTML     41K 
17: R2          Consolidated Balance Sheets                         HTML    115K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
19: R4          Consolidated Statements of Operations               HTML     81K 
20: R5          Consolidated Statements of Comprehensive (Loss)     HTML     35K 
                Income                                                           
21: R6          Consolidated Statement of Changes in Equity         HTML     78K 
22: R7          Consolidated Statements of Cash Flows               HTML    114K 
23: R8          Basis of Presentation and Organization              HTML     38K 
24: R9          Initial Public Offering                             HTML     41K 
25: R10         Cash                                                HTML     29K 
26: R11         Accounts Receivable                                 HTML     28K 
27: R12         Fair Value Measurements                             HTML     91K 
28: R13         Accrued Expenses and Other Current Liabilities      HTML     37K 
29: R14         Variable Interest Entities                          HTML     29K 
30: R15         Noncontrolling Interests Subject to Put Provisions  HTML     38K 
31: R16         Debt                                                HTML     52K 
32: R17         Income Taxes                                        HTML     27K 
33: R18         Stock-Based Compensation                            HTML     64K 
34: R19         (Loss) Earnings Per Share                           HTML     55K 
35: R20         Related Party Transactions                          HTML     35K 
36: R21         Commitments and Contingencies                       HTML     27K 
37: R22         Certain Legal Matters                               HTML     34K 
38: R23         Changes in Ownership Interest in Consolidated       HTML     38K 
                Subsidiaries                                                     
39: R24         Basis of Presentation and Organization (Policies)   HTML     40K 
40: R25         Cash (Tables)                                       HTML     34K 
41: R26         Fair Value Measurements (Tables)                    HTML     84K 
42: R27         Accrued Expenses and Other Current Liabilities      HTML     38K 
                (Tables)                                                         
43: R28         Debt (Tables)                                       HTML     47K 
44: R29         Stock-Based Compensation (Tables)                   HTML     64K 
45: R30         (Loss) Earnings Per Share (Tables)                  HTML     52K 
46: R31         Changes in Ownership Interest in Consolidated       HTML     35K 
                Subsidiaries (Tables)                                            
47: R32         Basis of Presentation and Organization (Details)    HTML     51K 
48: R33         Initial Public Offering (Details)                   HTML    107K 
49: R34         Cash (Details)                                      HTML     29K 
50: R35         Accounts Receivable (Details)                       HTML     30K 
51: R36         Fair Value Measurements (Details)                   HTML     30K 
52: R37         Fair Value Measurements - Schedule of fair values   HTML     58K 
                (Details)                                                        
53: R38         FAIR VALUE MEASUREMENTS - Fair value rollforward    HTML     30K 
                for tax receivable agreement liability (Details)                 
54: R39         Accrued Expenses and Other Current Liabilities      HTML     41K 
                (Details)                                                        
55: R40         Variable Interest Entities (Details)                HTML     24K 
56: R41         Noncontrolling Interests Subject to Put Provisions  HTML     25K 
                (Details)                                                        
57: R42         DEBT - Schedule of long-term debt (Details)         HTML     41K 
58: R43         DEBT - Scheduled maturities of long-term debt       HTML     40K 
                (Details)                                                        
59: R44         DEBT - Narrative (Details)                          HTML     51K 
60: R45         Income Taxes (Details)                              HTML     28K 
61: R46         STOCK-BASED COMPENSATION - Schedule of Expense      HTML     30K 
                (Details)                                                        
62: R47         STOCK-BASED COMPENSATION - Narrative (Details)      HTML     48K 
63: R48         STOCK-BASED COMPENSATION - Assumptions used for     HTML     33K 
                options granted (Details)                                        
64: R49         STOCK-BASED COMPENSATION - Option activity          HTML     54K 
                (Details)                                                        
65: R50         STOCK-BASED COMPENSATION - Restricted stock awards  HTML     40K 
                (Details)                                                        
66: R51         (Loss) Earnings Per Share (Details)                 HTML     56K 
67: R52         Related Party Transactions (Details)                HTML     58K 
68: R53         Commitments and Contingencies (Details)             HTML     22K 
69: R54         Certain Legal Matters (Details)                     HTML     28K 
70: R55         Changes in Ownership Interest in Consolidated       HTML     34K 
                Subsidiaries (Details)                                           
72: XML         IDEA XML File -- Filing Summary                      XML    121K 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX     67K 
10: EX-101.INS  XBRL Instance -- ara-20170331                        XML   1.02M 
12: EX-101.CAL  XBRL Calculations -- ara-20170331_cal                XML    194K 
13: EX-101.DEF  XBRL Definitions -- ara-20170331_def                 XML    428K 
14: EX-101.LAB  XBRL Labels -- ara-20170331_lab                      XML   1.34M 
15: EX-101.PRE  XBRL Presentations -- ara-20170331_pre               XML    757K 
11: EX-101.SCH  XBRL Schema -- ara-20170331                          XSD    126K 
73: ZIP         XBRL Zipped Folder -- 0001498068-17-000035-xbrl      Zip    165K

‘R31’ — Changes in Ownership Interest in Consolidated Subsidiaries (Tables)

This is an IDEA Financial Report. [ Alternative Formats ]

CHANGES IN OWNERSHIP INTEREST IN CONSOLIDATED SUBSIDIARIES (Tables)

3 Months Ended

Mar. 31, 2017

Noncontrolling Interest [Abstract]

Schedule of effect of changes in Company's ownership interest on Company's equity

The effects of changes in the Company's ownership interest on the Company's equity are as follows:



	Three Months Ended March 31,
	2017			2016
Net (loss) income attributable to American Renal Holdings Associates, Inc.	$	(1,251	)	$	3,756
Increase in paid-in capital for the sales of noncontrolling interest	—			—
Decrease in paid-in capital for the purchase of noncontrolling interest and adjustments to ownership interest	(1,272		)	—
Net transfers to noncontrolling interests	(1,272		)	—
Net (loss) income attributable to American Renal Holdings Associates, Inc., net of transfers to noncontrolling interests	$	(2,523	)	$	3,756

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	5/9/17	8-K
For Period end:	3/31/17
		List all Filings

↑Top

Filing Submission 0001498068-17-000035 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

American Renal Associates Holdings, Inc. – ‘10-Q’ for 3/31/17 – ‘R31’

On: Tuesday, 5/9/17, at 4:50pm ET · For: 3/31/17 · Accession #: 1498068-17-35 · File #: 1-37751

Previous ‘10-Q’: ‘10-Q’ on 11/10/16 for 9/30/16 · Next: ‘10-Q’ on 8/8/17 for 6/30/17 · Latest: ‘10-Q’ on 11/6/20 for 9/30/20

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

‘R31’ — Changes in Ownership Interest in Consolidated Subsidiaries (Tables)

This is an IDEA Financial Report. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

American Renal Associates Holdings, Inc. – ‘10-Q’ for 3/31/17 – ‘R31’

On: Tuesday, 5/9/17, at 4:50pm ET · For: 3/31/17 · Accession #: 1498068-17-35 · File #: 1-37751

Previous ‘10-Q’: ‘10-Q’ on 11/10/16 for 9/30/16 · Next: ‘10-Q’ on 8/8/17 for 6/30/17 · Latest: ‘10-Q’ on 11/6/20 for 9/30/20

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘R31’ — Changes in Ownership Interest in Consolidated Subsidiaries (Tables)

This is an IDEA Financial Report. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents